Schwabe R F, Stremmel W
Abteilung Innere Medizin IV, Medizinische Universitätsklinik Heidelberg.
Praxis (Bern 1994). 1998 Oct 14;87(42):1403-7.
Chronic hepatitis B and hepatitis C virus infections maintain a significant risk for the development of liver cirrhosis and hepatocellular carcinoma and cause a considerable morbidity in the population. Among patients with chronic HBV infection and histologically confirmed hepatitis the annual incidence of liver cirrhosis is 2%. The risk for hepatocellular carcinoma in chronic HBsAg carriers is elevated about 40-230 fold. 20-30% of patients with chronic HCV infection will develop cirrhosis over 20-30 years. Hepatocellular carcinoma evolves yearly in about 3% of patients with chronic HCV infection and cirrhosis, whereas HCV-carriers without cirrhosis usually do not develop hepatocellular carcinoma. The high incidence of serious sequelae warrants a regular surveillance of chronic virus carriers.
慢性乙型肝炎和丙型肝炎病毒感染会显著增加肝硬化和肝细胞癌的发病风险,并在人群中导致相当高的发病率。在慢性HBV感染且经组织学确诊为肝炎的患者中,肝硬化的年发病率为2%。慢性HBsAg携带者患肝细胞癌的风险升高约40 - 230倍。20 - 30%的慢性HCV感染患者在20 - 30年内会发展为肝硬化。慢性HCV感染和肝硬化患者中,每年约有3%会发生肝细胞癌,而无肝硬化的HCV携带者通常不会发生肝细胞癌。严重后遗症的高发病率使得对慢性病毒携带者进行定期监测很有必要。